Status:
UNKNOWN
Effect of an Infant Formula on Infant Growth, Health and Immune Functions
Lead Sponsor:
Biostime, Inc.
Collaborating Sponsors:
Arla Foods
Children's Hospital of Fudan University
Conditions:
Health
Growth
Eligibility:
All Genders
1-30 years
Phase:
NA
Brief Summary
The specific objectives of this study are to evaluate the effects of bovine milk osteopontin added to infant formula on infant growth, health and immune functions.
Detailed Description
Breast-fed infants will be used as a reference group and formula-fed infants will be fed control formula or the same formula supplemented with Osteopontin at a concentration 50% or 100% of that of bre...
Eligibility Criteria
Inclusion
- Mothers
- Healthy, 19-40 years of age
- Plan to exclusively breast-fed or formula-fed
- Infants
Exclusion
- Gestational age \< 37 or \> 42 weeks
- Birth weight \< 2.5kg or \> 4 kg
- Having congenital diseases
- Having birth Asphyxia
- Having birth infections
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2013
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00970398
Start Date
September 1 2009
End Date
July 1 2013
Last Update
April 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Fudan University
Shanghai, China, 201102